Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Recessive mutations in the <i>CAPN1</i> gene have recently been identified in spastic paraplegia 76 (SPG76), a complex hereditary spastic paraplegia (HSP) that is combined with cerebellar ataxia, resulting in an ataxia‐spasticity disease spectrum. This study aims to assess the influence of <i>CAPN1</i> variants on the occurrence of SPG76 and identify factors potentially contributing to phenotypic heterogeneity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We screened a cohort of 240 unrelated HSP families for variants in <i>CAPN1</i> using high‐throughput sequencing analysis. We described in detail the clinical and genetic features of the SPG76 patients in our cohort and summarized all reported cases. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Six unreported <i>CAPN1</i>‐associated families containing eight patients with or without cerebellar ataxia were found in our cohort of HSP cases. These patients carried three previously reported homozygous truncating mutations (p.V64Gfs<sup>*</sup>103, c.759+1G>A, and p.R285<sup>*</sup>), and three additional novel compound heterozygous missense mutations (p.R481Q, p.P498L, and p.R618W). Lower limbs spasticity, hyperreflexia, and Babinski signs developed in about 94% of patients, with ataxia developing in 63% of cases. In total, 33 pathogenic mutations were distributed along the three reported functional domains of calpain‐1 protein, encoded by <i>CAPN1,</i> with no hotspot region. A comparison of gender distribution between the two groups indicated that female SPG76 patients were significantly more likely to present with complicated HSP than male patients (<i>P</i> = 0.015). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Interpretation</h3><p>Our study supports the clinically heterogeneous inter‐ and intra‐family variability of SPG76 patients, and demonstrates that gender and calpain‐1 linker structure may contribute to clinical heterogeneity in SPG76 cases.</p></section>

Co-occurrence of CAPN3 homozygous mutation and CCTG expansion in the CNBP gene in a patient with muscular dystrophy

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

Case report: A novel mutation of the CAPN3 gene in a Chinese family with limb-girdle muscular dystrophy type 2A

A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy

The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3‐related muscular dystrophy

Variants of CAPN3 Cause Limb-Girdle Muscular Dystrophy Type 2A in Two Chinese Families.

A recurrent rare intronic variant in CAPN3 alters mRNA splicing and causes autosomal recessive limb-girdle muscular dystrophy-1 in three Pakistani pedigrees

Molecular Landscape of CAPN3 Mutations in Limb-Girdle Muscular Dystrophy Type R1: from a Chinese Multicentre Analysis to a Worldwide Perspective

One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families

Myotonia Congenita and Myotonic Dystrophy in the Same Family: Coexistence of a CLCN1 Mutation and Expansion in the CNBP (ZNF9) Gene

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

Clinical and Genetic Diversity of PMP22 Mutations in a Large Cohort of Chinese Patients with Charcot-Marie-Tooth Disease.

Missense mutation of c.635 T > C in <i>CAPN3</i> impairs muscle injury repair in a Limb-Girdel Muscular Dystropy Model

Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia

Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations

A Case of a Patient with Calpainopathy Carrying Compound Heterozygous Mutations of a de novo Pathogenic Variant of c.1333G>A and a Novel Variant of c.1331C>T in CAPN3

A retrospective study on the clinical and molecular outcomes of calpainopathy in a Turkish patient cohort

IGHMBP2 -Related Clinical and Genetic Features in a Cohort of Chinese Charcot–Marie–Tooth Disease Type 2 Patients

Concurrent occurrence of a de novo MACF1 mutation and an inherited 16p13.11 microduplication in a preterm neonate with multiple congenital malformations, hypotonia, excessive joint activity, feeding difficulties and respiratory problems：a case report

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy

Two Novel Homozygous Mutations of CAPN1 in Chinese Patients with Hereditary Spastic Paraplegia and Literatures Review